Rates of Anti-Reflux Procedures Not Consistent Among Pediatric Hospitals

Published Online: Monday, June 9, 2014
Follow Pharmacy_Times:
A recent study found that rates of anti-reflux procedures vary greatly among pediatric hospitals and that there are no standardized guidelines for referrals for such procedures. 

While few children develop gastroesophageal reflux disease (GERD) that is severe enough to warrant surgery, those who aspirate, fail to respond to medical management, or have issues with medication dependence, tolerance, or adherence are generally good candidates for a procedure.

Although the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) recommends operative therapy for children with GERD who have intractable symptoms, as well as those at risk for life-threatening complications, pediatric hospitals report widely varying rates of anti-reflux procedures (ARP). Most quality-measuring organizations believe this inconsistency among institutions represents an opportunity to improve care and save money.

In a study published in the May 2014 issue of Surgery, researchers at the Indiana University School of Medicine and the Regenstrief Institute in Indianapolis revealed the lack of standardized referral guidelines for pediatric subspecialists is likely the cause of the variation in ARP rates across hospitals.

To read the rest of this article, click here.
Related Articles
Three individuals who were in close contact with an Ebola patient have been placed under quarantine.
It is compulsory for pharmacists to counsel all patients receiving opioids, evaluate the potential benefit of a naloxone reversal device, and contact the opioid prescriber if such a device is deemed appropriate.
As a result of confusing sensations of breathlessness with asthma symptoms, overweight and obese children tend to report poorer asthma control and overuse rescue medications.
While there is currently no standard treatment, vaccine, or cure for Ebola, there are still some experimental treatments in 3 drug class with more to come.
Latest Issues
$auto_registration$